Table 2

Screening and data collection across the trial: summary of the key trial processes from receipt of the invite reply from the potential participant to the data collection time points

CRFCompleted byDatabasePreconsentBaseline3 m6 m12 mOngoing or during treatmentRef
Invite replyPRTXna
Screening QuestionnaireP/TTMXna
ConsentPRXna
Sample requisition formRNRTXna
Adverse events formTTMXna
Drop-out event formTTMXna
Note review formTTMXna
IBS-SSSPRXXXX23
WASASPRXXXX24
SGAPRXXX25
EQ5DPRXXXX26
Patient enablementPRXXX27
Hospital Anxiety and Depression ScalePRXXXX28
Client Service Receipt InventoryPRXXXX29
Cognitive Scale CG-FBDPRXXXX30
B-IPQ for IBSPRXXXX31
IBS Behavioural Responses QuestionnairePRXXXX32
BESPRXXXX33
“Impoverished Emotional Experience (IEE)” factor of the Emotional Processing Scale-25PRXXXX34
PANASPRXXXX35
DemographicsPRXna
About your IBSPRXna
Safety questionsPRXXXna
Rating of satisfactionPRXXX22
Thoughts on my treatmentPRXXX36
Therapist databaseTMTXna
  • BES, Beliefs about Emotions Scale; B-IPQ, Brief Illness Perception Questionnaire; CG-FBD, Cognitive Scale for Functional Bowel Disoders; CRF, Case Report Form; IBS, Irritable bowel syndrome; IBS-SSS, IBS Symptom Severity Score; M, MACRO Clinical Trials Unit database; MT, MACRO Therapist database; na, not significant; P, patient; PANAS, Positive and Negative Affect Schedule; SGA, Subject's Global Assessment of Relief; R, LifeGuide Regul8; RN, Research Nurse/Phlebotomist; RT, Research Team database; T, therapist; TT, trial team; WASAS, Work & Social Adjustment Scale.